446
Participants
Start Date
September 30, 2000
Primary Completion Date
October 31, 2003
Study Completion Date
October 31, 2003
Azimilide Dihydrochloride
125 mg azimilide tablets once a day for 3 days in hospital and 125 mg azimilide tablets once a day for 6 months as outpatient
Placebo
placebo tablets once a day for 3 days in hospital and placebo tablets once a day for 6 months as outpatient
Tri-State Medical Group Cardiology, Beaver
Cardiovascular and Critical Care Associates, P.C., Pittsburgh
Milton S. Hershey Medical Center, Hershey
Heart Care Group PC, Allentown
The Pavillion, Jenkintown
Cardiology Foundation of Lankenau, Wynnewood
UPHS/Presbyterian Medical Center, Philadelphia
The George Washington University MFA, Washington D.C.
Riverside Regional Medical Center, Newport News
Duke Medical Center, Durham
Charleston Cardiology, Charleston
VA Medical Center, Decatur
Cardiology Consultants, Daytona Beach
Cardiology Reasearch Assiocates, Ormond Beach
Jacksonville Center for Clinical Research, Jacksonville
Florida Cardiology, Orlando
Khalid Hasan Sheikh 80 Fortenberry Road, Merritt Island
C/O Research Office Attn: Cardiovascular Research Dept., Fort Lauderdale
Lakeland Regional Medical, Lakeland
The Heart Group, PC, Mobile
Stern Cardiovascular Center Research Department, Memphis
University of Louisville-Cardiology, Louisville
Louisville Cardiology Medical Group, P.S.C., Louisville
University Hospitals of Cleveland, Cleveland
Lindner Clinical Trial Ctr., Cincinnati
The Care Group, Indianapolis
Heart Center Medical Group, Fort Wayne
Riverside Osteopathic Hospital, Trenton
Thoracic & Cardiovascular Healthcare Foundation, Lansing
Wisconsin Center for Clinical Research, Elkhorn
Wisconsin Center for Clinical Research, Milwaukee
Beloit Clinic, SC, Beloit
Dean/Riverview Clinic, Janesville
University of Wisconsin Madison, Madison
St. Paul Heart Clinic, Saint Paul
VA Medical Center Therapeutic Section, Minneapolis
Regional Heart Center, Duluth
Altru Health System Research Center, Grand Forks
Elgin Cardiology Associates, Elgin
Advocate Christ Medical Center, Oak Lawn
Tulane University, New Orleans
Cardiovascular Institute of the South, Houma
Cardiovascular Instiute of the South, Morgan City
Richard Gilmore 501 S. Ryan Street, Lake Charles
UT Southwestern Medical Center, Dallas
Methodist Hospital, Houston
Heart and Vascular Inst. of Texas, PA, San Antonio
Western Cardiology Assoc., Denver
University Medical Center, Tucson
Good Samaritan Hospital, Los Angeles
LAC + USC Medical Center, Los Angeles
Cardiology Section, West Los Angeles VA Hospital, Los Angeles
ARI Clinical Trials, Redondo Beach
La Mesa Cardiac Center, a Medical Group, La Mesa
San Diego Cardiovascular Research Associates, Encinitas
Cardiology Associates, San Diego
Inland Clinical Research, Riverside
Cardiovascular Associates of Penisula, Burlingame
Sutter Gould Medical Foundation, Modesto
Merced Heart Associates, Merced
Regional Cardiology Assoc., Sacramento
Hillsboro Cardiology, Hillsboro
Oregon Health Sciences University, Portland
Daniel Gottlieb 16259 Sylvester Road SW Suite 401, Seattle
FHS Research, Tacoma
Hartford Hospital, Hartford
Androscoggin Cardiology Associates Research, Auburn
Maine Medical Center, Portland
University of Massachusett, Worcester
University of Calgary, Calgary
Rockyview General Hospital CV Lab Research, Calgary
Cardiology Research St. Paul's Hospital, Vancouver
Health Sciences Centre, Winnipeg
Neureka Research Corporation, Greater Sudbury
Hamilton Health Sciences Crop, Hamilton
Cardiac Investigation Unit, London
University of Ottawa Heart Institute, Ottawa
St. Michael's Hospital, Toronto
Montreal Heart Institute, Montreal
Recherche Cardiologie, Montreal
Hospital Sacre-Coeur de Montreal, Montreal
Quebec Heart Institute, Sainte-Foy
Lead Sponsor
Forest Laboratories
INDUSTRY